Other investigators [3,15] proposed that the COVID-19 vaccines can stimulate innate immunity through Toll-like receptors 3 and 7, and the induction of type I interferons and potent inflammatory cytokines, which may negatively affect antigen expression, potentially interfering with the suppression of VZV reactivation. Here, TLR3 is linked to COVID-19.